Selegiline hydrochloride

Selegiline hydrochloride

CAS number
14611-52-0
Application
Selegiline, a monoamine oxidase (MAO) inhibitor, is used as an adjunct treatment for patients with Parkinson disease and a major depressive disorder in adults.
Molecular weight
223.74 g/mol
Molecular formula
C13H17N•HCl
Routes
Oral

SOCOSUR PDE monographs are a quick and efficient way to obtain:

  • Risks identification
  • Identification of potential critical effects
  • Rationale for NOAEL values selection
  • Complete description of adjustment factors F1 to F5 as well as PK correction
  • Complete review of all relevant pharmaceutical and medical databases, public or private, European or not in accordance with EMA guideline EMA/CHMP/CVMP/SWP/169430/2012, signed by an European toxicological expert with full CV

Benefits of such PDE monograph

A 16 to 25 pages report optimized in case of Regulatory Body inspection with all calculation details and all bibliographic references linked to these calculations.

How to initiate a quotation request and a supplier qualification within your quality system?